1-2 of 2
Ann T. Farrell
Close
Sort by
Journal Articles

End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain

Ann T. Farrell, Julie Panepinto, C. Patrick Carroll, Deepika S. Darbari, Ankit A. Desai, Allison A. King, Robert J. Adams, Tabitha D. Barber, Amanda M. Brandow, Michael R. DeBaun, Manus J. Donahue, Kalpna Gupta, Jane S. Hankins, Michelle Kameka, Fenella J. Kirkham, Harvey Luksenburg, Shirley Miller, Patricia Ann Oneal, David C. Rees, Rosanna Setse, Vivien A. Sheehan, John Strouse, Cheryl L. Stucky, Ellen M. Werner, John C. Wood, William T. Zempsky
Journal: Blood Advances
Blood Adv (2019) 3 (23): 3982–4001.
https://doi.org/10.1182/bloodadvances.2019000882
Published: 2019
Includes: Supplemental data
Journal Articles

End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings

Ann T. Farrell, Julie Panepinto, Ankit A. Desai, Adetola A. Kassim, Jeffrey Lebensburger, Mark C. Walters, Daniel E. Bauer, Rae M. Blaylark, Donna M. DiMichele, Mark T. Gladwin, Nancy S. Green, Kathryn Hassell, Gregory J. Kato, Elizabeth S. Klings, Donald B. Kohn, Lakshmanan Krishnamurti, Jane Little, Julie Makani, Punam Malik, Patrick T. McGann, Caterina Minniti, Claudia R. Morris, Isaac Odame, Patricia Ann Oneal, Rosanna Setse, Poornima Sharma, Shalini Shenoy
Journal: Blood Advances
Blood Adv (2019) 3 (23): 4002–4020.
https://doi.org/10.1182/bloodadvances.2019000883
Published: 2019
Includes: Supplemental data